HealthEquity (HQY) Tops Q3 EPS by 6c, provides guidance

HealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.78, $0.06 better than the analyst estimate of $0.72. Revenue for the quarter came in at $300.4 million versus the consensus estimate of $289.92 million.

GUIDANCE:

HealthEquity sees FY2025 EPS of $3.08-$3.16. HealthEquity sees FY2025 revenue of $1.185-1.195 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• EU opens antidumping review of Chinese silicon metal imports
• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance